United States Federal Circuit
Caraco Pharm. Labs., Ltd. v. Forest Labs., Inc., 2007-1404
In an action brought under the Declaratory Judgment Act and the provision of the Hatch-Waxman Act establishing civil actions for patent certainty, dismissal of plaintiff's declaratory judgment action for noninfringement against defendants is reversed and remanded where: 1) in the context of the Hatch-Waxman framework, defendant's covenant not to sue plaintiff did not eliminate the controversy between the parties, and thus, the declaratory judgment action presents a continuing Article III controversy.
Appellate Information
- Decided 04/01/2008
- Published 04/01/2008
Judges
- Before GAJARSA, Circuit Judge, FRIEDMAN, Senior Circuit Judge, and PROST, Circuit Judge.
Court
- United States Federal Circuit
Counsel
- For Appellant:
- James F. Hurst, Winston & Strawn, LLP, of Chicago, IL, argued for plaintiff-appellant. With him on the brief were Derek J. Sarafa and Samuel S. Park. Of counsel on the brief were Steffen N. Johnson and Luke W. Goodrich, of Washington, DC.
- For Appellees:
- Gerald J. Flattmann, Jr., Kirkland & Ellis LLP, of New York, NY, argued for defendants-appellees. With him on the brief were John M. Desmarais, Christine Willgoos, and Benjamin A. Lasky. Of counsel was Peter J. Armenio.